Introduction Antibiotic pressure contributes to rising antibiotic resistance. Policy guidelines encourage rational prescribing behavior, but effectiveness in containing antibiotic use needs further assessment. This study therefore assessed the patterns of antibiotic use over a decade and analyzed the impact of different modes of guideline development and dissemination on inpatient antibiotic use. Methods Antibiotic use was calculated monthly as defined daily doses (DDD) per 100 bed days for nine antibiotic groups and overall. This time series compared trends in antibiotic use in five adjacent time periods identified as ‘Segments,’ divided based on differing modes of guideline development and implementation: Segment 1– Baseline prior to antibiotic guidelines development; Segment 2– During preparation of guidelines and booklet dissemination; Segment 3– Dormant period with no guidelines dissemination; Segment 4– Booklet dissemination of revised guidelines; Segment 5– Booklet dissemination of revised guidelines with intranet access. Regression analysis adapted for segmented time series and adjusted for seasonality assessed changes in antibiotic use trend. Results Overall antibiotic use increased at a monthly rate of 0.95 (SE = 0.18), 0.21 (SE = 0.08) and 0.31 (SE = 0.06) for Segments 1, 2 and 3, stabilized in Segment 4 (0.05; SE = 0.10) and declined in Segment 5 (？0.37; SE = 0.11). Segments 1, 2 and 4 exhibited seasonal fluctuations. Pairwise segmented regression adjusted for seasonality revealed a significant drop in monthly antibiotic use of 0.401 (SE = 0.089; p<0.001) for Segment 5 compared to Segment 4. Most antibiotic groups showed similar trends to overall use. Conclusion Use of overall and specific antibiotic groups showed varied patterns and seasonal fluctuations. Containment of rising overall antibiotic use was possible during periods of active guideline dissemination. Wider access through intranet facilitated significant decline in use. Stakeholders and policy makers are urged to develop guidelines, ensure active dissemination and enable accessibility through computer networks to contain antibiotic use and decrease antibiotic pressure.
References
[1]
WHO. The top 10 causes of death (n.d.). WHO. Available: http://www.who.int/mediacentre/factsheet？s/fs310/en/index.html. Accessed 2013 July 23.
[2]
Dhillon PK, Jeemon P, Arora NK, Mathur P, Maskey M, et al. (2012) Status of epidemiology in the WHO South-East Asia region: burden of disease, determinants of health and epidemiological research, workforce and training capacity. Int J Epidemiol 41: 847–860 doi:10.1093/ije/dys046.
[3]
Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, et al.. (2011) Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull 16.
[4]
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, et al. (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597–602 doi:10.1016/S1473-3099(10)70143-2.
[5]
Mathai E, Chandy S, Thomas K, Antoniswamy B, Joseph I, et al. (2008) Antimicrobial resistance surveillance among commensal Escherichia coli in rural and urban areas in Southern India. Trop Med Int Health TM IH 13: 41–45 doi:10.1111/j.1365-3156.2007.01969.x.
[6]
Kaul S, Brahmadathan KN, Jagannati M, Sudarsanam TD, Pitchamuthu K, et al. (2007) One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India. Indian J Med Microbiol 25: 230–235. doi: 10.4103/0255-0857.34764
[7]
Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD (2010) Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 340: c2096. doi: 10.1136/bmj.c2096
[8]
Goossens H, Ferech M, Vander Stichele R, Elseviers M (2005) ESAC Project Group (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579–587 doi:10.1016/S0140-6736(05)17907-0.
[9]
S KIK, Chandy SJ, Jeyaseelan L, Kumar R, Suresh S (2008) Antimicrobial prescription patterns for common acute infections in some rural & urban health facilities of India. Indian J Med Res 128: 165–171.
[10]
Knobler SL, Lemon SM, Najafi M, Burroughs T (2003) WHO Global Strategy for Containment of Antimicrobial Resistance: Executive Summary. Available: http://www.ncbi.nlm.nih.gov/books/NBK971？27/. Accessed 2013 July 23.
[11]
Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, et al. (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis Off Publ Infect Dis Soc Am 44: 159–177 doi:10.1086/510393.
[12]
Davey P, Brown E, Charani E, Fenelon L, Gould IM, et al. (2013) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 4: CD003543 doi:10.1002/14651858.CD003543.pub3.
[13]
Goossens H (2009) Antibiotic consumption and link to resistance. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 15 Suppl 312–15 doi:10.1111/j.1469-0691.2009.02725.x.
[14]
SUPPLEMENT BOOK - CMCYear2011.pdf (n.d.). Available: http://www.cmch-vellore.edu/pdf/CMCYear2？011.pdf. Accessed 2013 July 23.
[15]
WHOCC - ATC/DDD Index (n.d.). Available: http://www.whocc.no/atc_ddd_index/. Accessed 2013 July 23.
[16]
Naumova EN, Jagai JS, Matyas B, DeMaria A Jr, MacNeill IB, et al. (2007) Seasonality in six enterically transmitted diseases and ambient temperature. Epidemiol Infect 135: 281–292 doi:10.1017/S0950268806006698.
[17]
Jagai JS, Sarkar R, Castronovo D, Kattula D, McEntee J, et al. (2012) Seasonality of rotavirus in South Asia: a meta-analysis approach assessing associations with temperature, precipitation, and vegetation index. PloS One 7: e38168 doi:10.1371/journal.pone.0038168.
[18]
Lofgren E, Fefferman N, Doshi M, Naumova EN (2007) Assessing seasonal variation in multisource surveillance data: annual harmonic regression. Intelligence and Security Informatics: Biosurveillance. Springer. pp. 114–123. Available: http://link.springer.com/chapter/10.1007？/978-3-540-72608-1_11. Accessed 2013 Oct 27.
[19]
Naumova EN, Must A, Laird NM (2001) Tutorial in Biostatistics: Evaluating the impact of “critical periods” in longitudinal studies of growth using piecewise mixed effects models. Int J Epidemiol 30: 1332–1341. doi: 10.1093/ije/30.6.1332
[20]
Pitout JDD (2010) Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70: 313–333 doi:10.2165/11533040-000000000-00000.
[21]
Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis Off Publ Infect Dis Soc Am 44 Suppl 2S27–72 doi:10.1086/511159.
[22]
Amitabh V, Singhal A, Kumar S, Patel N, Rizvi YS, et al. (2012) Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia. Lung India Off Organ Indian Chest Soc 29: 248–253 doi:10.4103/0970-2113.99109.
[23]
Ahuja SD, Ashkin D, Avendano M, Banerjee R, Bauer M, et al.. (2012) Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients. PLoS Med 9. Available: http://www.ncbi.nlm.nih.gov/pmc/articles？/PMC3429397/. Accessed 2013 July 23.
[24]
Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME (2011) Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 71: 2277–2294 doi:10.2165/11597020-000000000-00000.
[25]
Joshi S, Ray P, Manchanda V, Bajaj J, Chitnis DS, et al. (2013) Methicillin resistant Staphylococcus aureus (MRSA) in India: Prevalence & susceptibility pattern. Indian J Med Res 137: 363–369.
[26]
Kumar S, Wanchu A, Abeygunasekera N, Sharma A, Singh S, et al. (2012) Profile of Presentation of Human Immunodeficiency Virus Infection in North India, 2003-2007. Indian J Community Med Off Publ Indian Assoc Prev Soc Med 37: 158–164 doi:10.4103/0970-0218.99914.
[27]
Das A, Anvikar AR, Cator LJ, Dhiman RC, Eapen A, et al. (2012) Malaria in India: The Center for the Study of Complex Malaria in India. Acta Trop 121: 267–273 doi:10.1016/j.actatropica.2011.11.008.
[28]
Mathai E, Rolain JM, Verghese GM, Abraham OC, Mathai D, et al. (2003) Outbreak of scrub typhus in southern India during the cooler months. Ann N Y Acad Sci 990: 359–364. doi: 10.1111/j.1749-6632.2003.tb07391.x
[29]
Kaurthe J (2013) Increasing Antimicrobial Resistance and Narrowing Therapeutics in Typhoidal Salmonellae. J Clin Diagn Res JCDR 7: 576–579 doi:10.7860/JCDR/2013/4765.2831.
[30]
A report on Swidish antibiotic utilisation and resistance in human medicine - Swedres 2010 final.pdf (n.d.). Available: http://www.strama.se/uploads/docs/Swedre？s%202010%20final.pdf. Accessed 2013 Oct 9.
[31]
Williams A, Mathai AS, Phillips AS (2011) Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India. J Pharm Bioallied Sci 3: 531–536 doi:10.4103/0975-7406.90108.
[32]
Pathak A, Mahadik K, Dhaneria SP, Sharma A, Eriksson B, et al. (2012) Surveillance of Antibiotic Consumption Using the “Focus of Infection” Approach in 2 Hospitals in Ujjain, India. PLoS ONE 7: e38641 doi:10.1371/journal.pone.0038641.
[33]
T？ngdén T, Eriksson B-M, Melhus ？, Svennblad B, Cars O (2011) Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae. J Antimicrob Chemother 66: 1161–1167 doi:10.1093/jac/dkr053.
[34]
Thursky KA, Buising KL, Bak N, Macgregor L, Street AC, et al. (2006) Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. Int J Qual Health Care J Int Soc Qual Health Care ISQua 18: 224–231 doi:10.1093/intqhc/mzi095.
[35]
Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, et al. (2003) Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother 52: 842–848 doi:10.1093/jac/dkg459.
[36]
Meyer E, Buttler J, Schneider C, Strehl E, Schroeren-Boersch B, et al. (2007) Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother 59: 1148–1154 doi:10.1093/jac/dkm088.
